Skip to main content
. 2020 Oct 30;8(1):e909. doi: 10.1212/NXI.0000000000000909

Table 3.

Management recommendations for patients with intermediate uveitis and/or MS

graphic file with name NEURIMMINFL2020033514t3.jpg